Jeries Kort

6PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersEconomic models and forecastingGene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Incidence and Associated Risk Factors in the Development of Carfilzomib-Induced Cardiovascular Toxicity.

|Jul 27, 2026
The ClinicalTrials.gov Landscape of Multiple Myeloma Clinical Trials: A 20-Year Analysis of Geographic Distribution and Growth Patterns: USMIRC Analysis.

|Jun 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

|May 26, 2026
High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.

|Oct 04, 2023
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.

Ehsan Malek, Jeries Kort, Leland Metheny

|Feb 25, 2020
Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma.

Jeries Kort, Amanda Chidiac, Rola El Sayed

Pageof 1

Frequent Collaborators

4 joint publications

Al-Ola Abdallah

4 joint publications

Zahra Mahmoudjafari

4 joint publications

Prerna Mewawalla

4 joint publications

Shebli Atrash